These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 798194

  • 21. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB, Donega P, Passaro A, Zanca R, Cattin L, Fonda M, Pauciullo P, Marotta G, Fellin R, Gasparrini S, Piliego T.
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [Abstract] [Full Text] [Related]

  • 22. Gemfibrozil--a new lipid lowering agent.
    Nash DT.
    J Med; 1980 Oct; 11(2-3):107-16. PubMed ID: 6931871
    [Abstract] [Full Text] [Related]

  • 23. Extrinsic factors affecting the response to gemfibrozil.
    Huunan-Seppälä A, Manninen V, Burton R, Eisalo A.
    Proc R Soc Med; 1976 Oct; 69 Suppl 2(Suppl 2):53-7. PubMed ID: 1019154
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of gemfibrozil on serum lipids.
    Samuel P.
    Am J Med; 1983 May 23; 74(5A):23-7. PubMed ID: 6573843
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure.
    Pasternack A, Vänttinen T, Solakivi T, Kuusi T, Korte T.
    Clin Nephrol; 1987 Apr 23; 27(4):163-8. PubMed ID: 3555908
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability.
    O'Neal DN, O'Brien RC, Timmins KL, Grieve GD, Lau KP, Nicholson GC, Kotowicz MA, Best JD.
    Diabet Med; 1998 Oct 23; 15(10):870-7. PubMed ID: 9796889
    [Abstract] [Full Text] [Related]

  • 31. The Gemfibrozil Study.
    Manninen V.
    Acta Med Scand Suppl; 1985 Oct 23; 701():83-8. PubMed ID: 3907298
    [Abstract] [Full Text] [Related]

  • 32. Gemfibrozil for hyperlipidemia.
    Med Lett Drugs Ther; 1982 Jun 25; 24(612):59-60. PubMed ID: 6953310
    [No Abstract] [Full Text] [Related]

  • 33. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C, Quadri A, Ratti S, Levi GF, Prandini BD.
    G Ital Cardiol; 1978 Jun 25; 8(7):743-51. PubMed ID: 355033
    [Abstract] [Full Text] [Related]

  • 34. Effect of gemfibrozil on serum lipids in man.
    Fenderson RW, Deutsch S, Menachemi E, Chin B, Samuel P.
    Angiology; 1982 Sep 25; 33(9):581-93. PubMed ID: 6751166
    [Abstract] [Full Text] [Related]

  • 35. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
    Lewis JE.
    Angiology; 1982 Sep 25; 33(9):603-12. PubMed ID: 6957156
    [Abstract] [Full Text] [Related]

  • 36. Para-aminosalicylic acid as a lipid-lowering agent.
    Vessby B, Lithell H, Boberg J, Hellsing K.
    Clin Pharmacol Ther; 1978 Jun 25; 23(6):651-7. PubMed ID: 348378
    [Abstract] [Full Text] [Related]

  • 37. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
    Passeri M, Cocchi C, Ceccato S, Palummeri E, Cucinotta D.
    G Clin Med; 1979 Jan 25; 60(1):49-64. PubMed ID: 456778
    [No Abstract] [Full Text] [Related]

  • 38. Lipokinetic studies with gemfibrozil (CI-719).
    Kissebah AH, Adams PA, Wynn V.
    Proc R Soc Med; 1976 Jan 25; 69 Suppl 2(Suppl 2):94-7. PubMed ID: 190610
    [Abstract] [Full Text] [Related]

  • 39. [The effect of etiroxate on serum lipids after myocardial infarction or in angina pectoris].
    Schwartzkopff W, Hoffmann H, Nijssen J, Etzel V.
    Med Klin; 1976 Sep 17; 71(38):1555-63. PubMed ID: 185504
    [Abstract] [Full Text] [Related]

  • 40. Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels.
    Mänttäri M, Koskinen P, Manninen V, Huttunen JK, Frick MH, Nikkilä EA.
    Atherosclerosis; 1990 Feb 17; 81(1):11-7. PubMed ID: 2407250
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.